Global Blood system drugs Market Research Report 2017-2022 by Players, Regions, Product Types & Applications

Published: Aug, 2017 | Pages: 121 | Publisher: Data Market Research (DMR)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Blood system drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report offers an overview of the market trends, drivers, and barriers with respect to the Blood system drugs market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes Blood system drugs market by by Antianemic Agents, by Antiplatelet drug, by Coagulant Drugs, by Anticoagulant and thrombolytic drugs, by blood volume expander, and application. Detailed analysis of key players, along with key growth strategies adopted by them is also covered in this report on Blood system drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report focuses Global market, it covers details as following:

Key Players
    ACTAVIS ELIZABETH
    AKORN
    ALLERGAN SALES LLC
    AMNEAL PHARMS
    APOTEX
    ARALEZ PHARMS
    ASTRAZENECA PHARMS
    AVEDRO INC
    BARR
    BAXTER HLTHCARE
    BIOKEY
    BRECKENRIDGE PHARM
    BRISTOL MYERS SQUIBB
    CHIESI USA INC
    CLOVER PHARMS
    EMCURE PHARMS LTD
    FERRING PHARMS INC
    FRESENIUS KABI USA
    GENENTECH
    GLAND PHARMA LTD
    GLENMARK PHARMS LTD
    HERITAGE PHARMA
    HOSPIRA
    INVAGEN PHARMS
    IPCA LABS LTD
    LUITPOLD
    MEDICURE
    MYLAN
    NEW RIVER
    PFIZER

Key Regions
    North America
        United States
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main types of products
Blood system drugs Market, by Antianemic Agents
    Ferrous sulfate
    Ferrous succinate
    RHUEPO
    Iron-dextrin
    Vitamin B12
    Folic acid
    Mecobalamin
    Cobamamide
    Epogen/Procrit
    NeoRecormon
    Dynepo
    Eporatio/Biopoin
    Aranesp/NESP
    Mircera/CERA
    Binocrit
    Abseamed
    Epoetin Alfa Hexal
    Retacrit/Silapo
Blood system drugs Market, by Antiplatelet drug
    Aspirin
    Dipyridamole
    Clopidogrel
    Prasugrel
    Ticagrelor
    Glycoprotein
    Aggrastat
    Cilostazol
    Ticlopidine
    Cangrelor
    Vorapaxar
    Atopaxar
    Sarpogrelate
Blood system drugs Market, by Coagulant Drugs
    Thrombin
    Etamsylate
    Menadione Sodium Bisulfite
    Vitamin K1
    Aminomethylbenzoic Acid
    Desmopressin acetate
    Human Coagulation Factor
    Prothrombin Complex
    Artificial fibrinogen
    Aminomethylbenzoic Acid
    Tranexamic acid
    Aprotinin
    Aminocaproic Acid
    Carbazochrome
    Pituitrin
Blood system drugs Market, by Anticoagulant and thrombolyti
    heparin
    urokinase
    Warfarin
    Bishydroxycoumarin
    Streptokinase
    Silteplase
Blood system drugs Market, by blood volume expander
    Hydroxyethyl starch 40
    Dextran
    Polyglucose

Blood system drugs Market, by Key Consumer
    department of hematology
    Internal Medicine
    department of surgery
    Pharmacy
    Hospital

 Table of Contents

Global Blood system drugs Market Research Report 2017-2022 by Players, Regions, Product Types & Applications
Chapter One Methodology and Data Source
    1.1 Methodology/Research Approach
        1.1.1 Research Programs/Design
        1.1.2 Market Size Estimation
        1.1.3 Market Breakdown and Data Triangulation
    1.2 Data Source
        1.2.1 Secondary Sources
        1.2.2 Primary Sources
    1.3 Disclaimer

Chapter Two Blood system drugs Market Overview
    2.1 Market Coverage
    2.2 Global Blood system drugs Market Sales Volume Revenue and Price 2012-2017

Chapter Three Blood system drugs by Key Players 2012-2017
    3.1 Global Blood system drugs Sales Volume Market Share by Key Players 2012-2017
    3.2 Global Blood system drugs Revenue Share by Key Players 2012-2017
    3.3 Global Key Players Blood system drugs Key Product Model and Market Performance
    3.4 Global Key Players Blood system drugs Key Target Consumers and Market Performance

Chapter Four Blood system drugs by Regions 2012-2017
    4.1 Global Blood system drugs Sales Market Share by Regions 2012-2017
    4.2 Global Blood system drugs Revenue Market Share by Regions 2012-2017
    4.3 Global Blood system drugs Price by Regions 2012-2017
    4.4 North America
        4.4.1 United States
        4.4.2 Canada
    4.5 Latin America
        4.5.1 Mexico
        4.5.2 Brazil
        4.5.3 Argentina
        4.5.4 Others in Latin America
    4.6 Europe
        4.6.1 Germany
        4.6.2 United Kingdom
        4.6.3 France
        4.6.4 Italy
        4.6.5 Spain
        4.6.6 Russia
        4.6.7 Netherland
        4.6.8 Others in Europe
    4.7 Asia & Pacific
        4.7.1 China
        4.7.2 Japan
        4.7.3 India
        4.7.4 Korea
        4.7.5 Australia
        4.7.6 Southeast Asia
            4.7.6.1 Indonesia
            4.7.6.2 Thailand
            4.7.6.3 Philippines
            4.7.6.4 Vietnam
            4.7.6.5 Singapore
            4.7.6.6 Malaysia
            4.7.6.7 Others in Southeast Asia
    4.8 Africa & Middle East
        4.8.1 South Africa
        4.8.2 Egypt
        4.8.3 Turkey
        4.8.4 Saudi Arabia
        4.8.5 Iran
        4.8.6 Others in Africa & Middle East

Chapter Five Blood system drugs Market by Product Types
    5.1 Blood system drugs, by Antianemic Agents 2012-2017
        5.1.1 Global Blood system drugs Sales Market Share by Antianemic Agents 2012-2017
        5.1.2 Global Blood system drugs Revenue Market Share by Antianemic Agents 2012-2017
        5.1.3 Global Blood system drugs Price by Antianemic Agents 2012-2017
        5.1.4 Ferrous sulfate
        5.1.5 Ferrous succinate
        5.1.6 RHUEPO
        5.1.7 Iron-dextrin
        5.1.8 Vitamin B12
        5.1.9Folic acid
        5.1.10Mecobalamin
        5.1.11Cobamamide
    5.2 Blood system drugs, by Antiplatelet drug 2012-2017
        5.2.1 Global Blood system drugs Sales Market Share by Antiplatelet drug 2012-2017
        5.2.2 Global Blood system drugs Revenue Market Share by Antiplatelet drug 2012-2017
        5.2.3 Global Blood system drugs Price by Antiplatelet drug 2012-2017
        5.2.4 Aspirin
        5.2.5 Dipyridamole
        5.2.6 Clopidogrel
        5.2.7 Prasugrel
        5.2.8 Ticagrelor
        5.2.9 Cangrelor
        5.2.10 Vorapaxar
        5.2.11 Atopaxar
        5.2.12 Sarpogrelate
    5.3 Blood system drugs, by Coagulant Drugs 2012-2017
        5.3.1 Global Blood system drugs Sales Market Share by Coagulant Drugs 2012-2017
        5.3.2 Global Blood system drugs Revenue Market Share by Coagulant Drugs 2012-2017
        5.3.3 Global Blood system drugs Price by Coagulant Drugs 2012-2017
        5.3.4 Thrombin
        5.3.5 Etamsylate
        5.3.6 Menadione Sodium Bisulfite
        5.3.7 Vitamin K1
        5.3.8 Aminomethylbenzoic Acid
    5.4 Blood system drugs, by Anticoagulant and thrombolytic 2012-2017
        5.4.1 Global Blood system drugs Sales Market Share by Anticoagulant and thrombolytic 2012-2017
        5.4.2 Global Blood system drugs Revenue Market Share by Anticoagulant and thrombolytic 2012-2017
        5.4.3 Global Blood system drugs Price by Anticoagulant and thrombolytic 2012-2017
        5.4.4 heparin
        5.4.5 urokinase
        5.4.6 Warfarin
        5.4.7 Bishydroxycoumarin
        5.4.8 Streptokinase
        5.4.9 Silteplase
    5.5 Blood system drugs, by blood volume expander 2012-2017
        5.5.1 Global Blood system drugs Sales Market Share by blood volume expander 2012-2017
        5.5.2 Global Blood system drugs Revenue Market Share by blood volume expander 2012-2017
        5.5.3 Global Blood system drugs Price by blood volume expander 2012-2017
        5.5.4 Hydroxyethyl starch 40
        5.5.5 Dextran
        5.5.6 Polyglucose

Chapter Six Global Key Players Profile
    6.1 ACTAVIS ELIZABETH
        6.1.1 ACTAVIS ELIZABETH Company Details and Competitors
        6.1.2 ACTAVIS ELIZABETH Key Blood system drugs Models and Performance
        6.1.3 ACTAVIS ELIZABETH Blood system drugs Business SWOT Analysis and Forecast
        6.1.4 ACTAVIS ELIZABETH Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.2 AKORN
        6.2.1 AKORN Company Details and Competitors
        6.2.2 AKORN Key Blood system drugs Models and Performance
        6.2.3 AKORN Blood system drugs Business SWOT Analysis and Forecast
        6.2.4 AKORN Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.3 ALLERGAN SALES LLC
        6.3.1 ALLERGAN SALES LLC Company Details and Competitors
        6.3.2 ALLERGAN SALES LLC Key Blood system drugs Models and Performance
        6.3.3 ALLERGAN SALES LLC Blood system drugs Business SWOT Analysis and Forecast
        6.3.4 ALLERGAN SALES LLC Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.4 AMNEAL PHARMS
        6.4.1 AMNEAL PHARMS Company Details and Competitors
        6.4.2 AMNEAL PHARMS Key Blood system drugs Models and Performance
        6.4.3 AMNEAL PHARMS Blood system drugs Business SWOT Analysis and Forecast
        6.4.4 AMNEAL PHARMS Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.5 APOTEX
        6.5.1 APOTEX Company Details and Competitors
        6.5.2 APOTEX Key Blood system drugs Models and Performance
        6.5.3 APOTEX Blood system drugs Business SWOT Analysis and Forecast
        6.5.4 APOTEX Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.6 ARALEZ PHARMS
        6.6.1 ARALEZ PHARMS Company Details and Competitors
        6.6.2 ARALEZ PHARMS Key Blood system drugs Models and Performance
        6.6.3 ARALEZ PHARMS Blood system drugs Business SWOT Analysis and Forecast
        6.6.4 ARALEZ PHARMS Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.7 ASTRAZENECA PHARMS
        6.7.1 ASTRAZENECA PHARMS Company Details and Competitors
        6.7.2 ASTRAZENECA PHARMS Key Blood system drugs Models and Performance
        6.7.3 ASTRAZENECA PHARMS Blood system drugs Business SWOT Analysis and Forecast
        6.7.4 ASTRAZENECA PHARMS Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.8 AVEDRO INC
        6.8.1 AVEDRO INC Company Details and Competitors
        6.8.2 AVEDRO INC Key Blood system drugs Models and Performance
        6.8.3 AVEDRO INC Blood system drugs Business SWOT Analysis and Forecast
        6.8.4 AVEDRO INC Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.9 BARR
        6.9.1 BARR Company Details and Competitors
        6.9.2 BARR Key Blood system drugs Models and Performance
        6.9.3 BARR Blood system drugs Business SWOT Analysis and Forecast
        6.9.4 BARR Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.10 BAXTER HLTHCARE
        6.10.1 BAXTER HLTHCARE Company Details and Competitors
        6.10.2 BAXTER HLTHCARE Key Blood system drugs Models and Performance
        6.10.3 BAXTER HLTHCARE Blood system drugs Business SWOT Analysis and Forecast
        6.10.4 BAXTER HLTHCARE Blood system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.11 BIOKEY
    6.12 BRECKENRIDGE PHARM
    6.13 BRISTOL MYERS SQUIBB
    6.14 CHIESI USA INC
    6.15 CLOVER PHARMS
    6.16 EMCURE PHARMS LTD
    6.17 FERRING PHARMS INC
    6.18 FRESENIUS KABI USA
    6.19 GENENTECH
    6.20 GLAND PHARMA LTD
    6.21 GLENMARK PHARMS LTD
    6.22 HERITAGE PHARMA
    6.23 HOSPIRA
    6.24 INVAGEN PHARMS
    6.25 IPCA LABS LTD
    6.26 LUITPOLD
    6.27 MEDICURE
    6.28 MYLAN
    6.29 NEW RIVER
    6.30 PFIZER

Chapter Seven Blood system drugs by Appliance 2012-2017
    7.1 Global Blood system drugs Sales Market Share by Appliance 2012-2017
    7.2 department of hematology
    7.3 Internal Medicine
    7.4 department of surgery
    7.5 Pharmacy
    7.6 Hospital
    7.7 Consuming Habit and Preference

Chapter Eight Industry Chain and Supply Chain
    8.1 Blood system drugs Industry Chain Structure
        8.1.1 R&D
        8.1.2 Raw Materials (Components)
        8.1.3 Manufacturing Plants
        8.1.4 Regional Trading (Import Export and Local Sales)
        8.1.5 Online Sales Channel
        8.1.6 Offline Channel
        8.1.7 End Users
    8.2 Blood system drugs Manufacturing
        8.2.1 Key Components
        8.2.2 Assembly Manufacturing
    8.3 Consumer Preference
    8.4 Behavioral Habits
    8.5 Marketing Environment

Chapter Nine Global Blood system drugs Market Size (Sales and Revenue) Forecast (2017-2022)
    9.1 Global Blood system drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
    9.2 Global Blood system drugs Sales () Forecast by Regions (2017-2022)
    9.3 Global Blood system drugs Sales () Forecast by Application (2017-2022)
    9.4 Global Blood system drugs Sales () Forecast by Antianemic Agents (2017-2022)
    9.5 Global Blood system drugs Sales () Forecast by Antiplatelet drug (2017-2022)
    9.6 Global Blood system drugs Sales () Forecast by Coagulant Drugs (2017-2022)
    9.7 Global Blood system drugs Sales () Forecast by Anticoagulant and thrombolytic (2017-2022)
    9.8 Global Blood system drugs Sales () Forecast by blood volume expander (2017-2022)

Chapter Ten Development Trend and Research Conclusion
    10.1 Development Trend
    10.2 Research Conclusion

List of Tables and Figures

    Table Global Blood system drugs Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
    Figure Global Blood system drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Blood system drugs Sales Volume () and Growth Rate (2012-2017)
    Table Global Blood system drugs Sales Volume () by Key Players (2012-2017)
    Table Global Blood system drugs Sales Volume Market Share by Key Players (2012-2017)
    Figure Global Blood system drugs Sales Volume Market Share by Key Players 2016
    Figure Global Blood system drugs Sales Volume Market Share by Key Players 2017
    Table Global Blood system drugs Revenue (Million USD) by Key Players (2012-2017)
    Table Global Blood system drugs Revenue Market Share by Key Players (2012-2017)
    Figure Global Blood system drugs Revenue Market Share by Key Players 2016
    Figure Global Blood system drugs Revenue Market Share by Key Players 2017
    Table Global Key Players Key Product Model and Market Performance
    Table Global Key Players Key Target Consumers and Market Performance
    Table Global Blood system drugs Sales () by Regions (2012-2017)
    Table Global Blood system drugs Sales Share by Regions (2012-2017)
    Figure Global Blood system drugs Sales Market Share by Regions in 2016
    Figure Global Blood system drugs Sales Market Share by Regions in 2017
    Table Global Blood system drugs Revenue (Million USD) by Regions (2012-2017)
    Table Global Blood system drugs Revenue Market Share by Regions (2012-2017)
    Figure Global Blood system drugs Revenue Market Share by Regions in 2016
    Figure Global Blood system drugs Revenue Market Share by Regions in 2017
    Table Global Blood system drugs Price () by Regions (2012-2017)
    Table North America Blood system drugs Sales () by Regions (2012-2017)
    Table North America Blood system drugs Revenue (Million USD) by Regions (2012-2017)
    Table North America Blood system drugs Sales Volume () by Key Players 2012-2017
    Figure North America Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Latin America Blood system drugs Sales () by Regions (2012-2017)
    Table Latin America Blood system drugs Revenue (Million USD) by Regions (2012-2017)
    Table Latin America Blood system drugs Sales Volume () by Key Players (2012-2017)
    Figure Latin America Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Europe Blood system drugs Sales () by Regions (2012-2017)
    Table Europe Blood system drugs Revenue (Million USD) by Regions (2012-2017)
    Table Europe Blood system drugs Sales Volume () by Key Players (2012-2017)
    Figure Europe Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Asia & Pacific Blood system drugs Sales () by Regions (2012-2017)
    Table Asia & Pacific Blood system drugs Revenue (Million USD) by Regions (2012-2017)
    Table Asia & Pacific Blood system drugs Sales Volume () by Key Players (2012-2017)
    Figure Asia & Pacific Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Africa & Middle East Blood system drugs Sales () by Regions (2012-2017)
    Table Africa & Middle East Blood system drugs Revenue (Million USD) by Regions (2012-2017)
    Table Africa & Middle East Blood system drugs Sales Volume () by Key Players (2012-2017)
    Figure Africa & Middle East Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Global Blood system drugs Sales () by Antianemic Agents (2012-2017)
    Table Global Blood system drugs Sales Market Share by Antianemic Agents (2012-2017)
    Figure Global Blood system drugs Sales Market Share by Antianemic Agents in 2016
    Table Global Blood system drugs Revenue (Million USD) by Antianemic Agents (2012-2017)
    Table Global Blood system drugs Revenue Market Share by Antianemic Agents (2012-2017)
    Figure Global Blood system drugs Revenue Market Share by Antianemic Agents in 2016
    Table Global Blood system drugs Price () by Antianemic Agents (2012-2017)
    Table Top Players of Ferrous sulfate Blood system drugs Products List
    Figure Global Ferrous sulfate Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Ferrous succinate Blood system drugs Products List
    Figure Global Ferrous succinate Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of RHUEPO Blood system drugs Products List
    Figure Global RHUEPO Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Iron-dextrin Blood system drugs Products List
    Figure Global Iron-dextrin Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Vitamin B12 Blood system drugs Products List
    Figure Global Vitamin B12 Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Global Blood system drugs Sales () by Antiplatelet drug (2012-2017)
    Table Global Blood system drugs Sales Market Share by Antiplatelet drug (2012-2017)
    Figure Global Blood system drugs Sales Market Share by Antiplatelet drug in 2016
    Table Global Blood system drugs Revenue (Million USD) by Antiplatelet drug (2012-2017)
    Table Global Blood system drugs Revenue Market Share by Antiplatelet drug (2012-2017)
    Figure Global Blood system drugs Revenue Market Share by Antiplatelet drug in 2016
    Table Global Blood system drugs Price () by Antiplatelet drug (2012-2017)
    Table Top Players of Aspirin Blood system drugs Products List
    Figure Global Aspirin Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Dipyridamole Blood system drugs Products List
    Figure Global Dipyridamole Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Clopidogrel Blood system drugs Products List
    Figure Global Clopidogrel Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Prasugrel Blood system drugs Products List
    Figure Global Prasugrel Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Ticagrelor Blood system drugs Products List
    Figure Global Ticagrelor Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Global Blood system drugs Sales () by Coagulant Drugs (2012-2017)
    Table Global Blood system drugs Sales Market Share by Coagulant Drugs (2012-2017)
    Figure Global Blood system drugs Sales Market Share by Coagulant Drugs in 2016
    Table Global Blood system drugs Revenue (Million USD) by Coagulant Drugs (2012-2017)
    Table Global Blood system drugs Revenue Market Share by Coagulant Drugs (2012-2017)
    Figure Global Blood system drugs Revenue Market Share by Coagulant Drugs in 2016
    Table Global Blood system drugs Price () by Coagulant Drugs (2012-2017)
    Table Top Players of Thrombin Blood system drugs Products List
    Figure Global Thrombin Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Etamsylate Blood system drugs Products List
    Figure Global Etamsylate Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Menadione Sodium Bisulfite Blood system drugs Products List
    Figure Global Menadione Sodium Bisulfite Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Vitamin K1 Blood system drugs Products List
    Figure Global Vitamin K1 Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Aminomethylbenzoic Acid Blood system drugs Products List
    Figure Global Aminomethylbenzoic Acid Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Global Blood system drugs Sales () by Anticoagulant and thrombolytic (2012-2017)
    Table Global Blood system drugs Sales Market Share by Anticoagulant and thrombolytic (2012-2017)
    Figure Global Blood system drugs Sales Market Share by Anticoagulant and thrombolytic in 2016
    Table Global Blood system drugs Revenue (Million USD) by Anticoagulant and thrombolytic (2012-2017)
    Table Global Blood system drugs Revenue Market Share by Anticoagulant and thrombolytic (2012-2017)
    Figure Global Blood system drugs Revenue Market Share by Anticoagulant and thrombolytic in 2016
    Table Global Blood system drugs Price () by Anticoagulant and thrombolytic (2012-2017)
    Table Top Players of heparin Blood system drugs Products List
    Figure Global heparin Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of urokinase Blood system drugs Products List
    Figure Global urokinase Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Warfarin Blood system drugs Products List
    Figure Global Warfarin Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Bishydroxycoumarin Blood system drugs Products List
    Figure Global Bishydroxycoumarin Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Streptokinase Blood system drugs Products List
    Figure Global Streptokinase Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Global Blood system drugs Sales () by blood volume expander (2012-2017)
    Table Global Blood system drugs Sales Market Share by blood volume expander (2012-2017)
    Figure Global Blood system drugs Sales Market Share by blood volume expander in 2016
    Table Global Blood system drugs Revenue (Million USD) by blood volume expander (2012-2017)
    Table Global Blood system drugs Revenue Market Share by blood volume expander (2012-2017)
    Figure Global Blood system drugs Revenue Market Share by blood volume expander in 2016
    Table Global Blood system drugs Price () by blood volume expander (2012-2017)
    Table Top Players of Hydroxyethyl starch 40 Blood system drugs Products List
    Figure Global Hydroxyethyl starch 40 Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Dextran Blood system drugs Products List
    Figure Global Dextran Blood system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Polyglucose Blood system drugs Products List
    Figure Global Polyglucose Blood system drugs Sales () and Growth Rate (2012-2017)
    Table ACTAVIS ELIZABETH Company Details and Competitors
    Table ACTAVIS ELIZABETH Key Blood system drugs Models and Performance
    Table ACTAVIS ELIZABETH Blood system drugs Business SWOT Analysis and Forecast
    Table ACTAVIS ELIZABETH Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure ACTAVIS ELIZABETH Blood system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure ACTAVIS ELIZABETH Blood system drugs Sales Market Share (%) in Global (2012-2017)
    Figure ACTAVIS ELIZABETH Blood system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure ACTAVIS ELIZABETH Blood system drugs Revenue Market Share (%) in Global (2012-2017)
    Table AKORN Company Details and Competitors
    Table AKORN Key Blood system drugs Models and Performance
    Table AKORN Blood system drugs Business SWOT Analysis and Forecast
    Table AKORN Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure AKORN Blood system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure AKORN Blood system drugs Sales Market Share (%) in Global (2012-2017)
    Figure AKORN Blood system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure AKORN Blood system drugs Revenue Market Share (%) in Global (2012-2017)
    Table ALLERGAN SALES LLC Company Details and Competitors
    Table ALLERGAN SALES LLC Key Blood system drugs Models and Performance
    Table ALLERGAN SALES LLC Blood system drugs Business SWOT Analysis and Forecast
    Table ALLERGAN SALES LLC Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure ALLERGAN SALES LLC Blood system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure ALLERGAN SALES LLC Blood system drugs Sales Market Share (%) in Global (2012-2017)
    Figure ALLERGAN SALES LLC Blood system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure ALLERGAN SALES LLC Blood system drugs Revenue Market Share (%) in Global (2012-2017)
    Table AMNEAL PHARMS Company Details and Competitors
    Table AMNEAL PHARMS Key Blood system drugs Models and Performance
    Table AMNEAL PHARMS Blood system drugs Business SWOT Analysis and Forecast
    Table AMNEAL PHARMS Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure AMNEAL PHARMS Blood system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure AMNEAL PHARMS Blood system drugs Sales Market Share (%) in Global (2012-2017)
    Figure AMNEAL PHARMS Blood system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure AMNEAL PHARMS Blood system drugs Revenue Market Share (%) in Global (2012-2017)
    Table APOTEX Company Details and Competitors
    Table APOTEX Key Blood system drugs Models and Performance
    Table APOTEX Blood system drugs Business SWOT Analysis and Forecast
    Table APOTEX Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure APOTEX Blood system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure APOTEX Blood system drugs Sales Market Share (%) in Global (2012-2017)
    Figure APOTEX Blood system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure APOTEX Blood system drugs Revenue Market Share (%) in Global (2012-2017)
    Table ARALEZ PHARMS Company Details and Competitors
    Table ARALEZ PHARMS Key Blood system drugs Models and Performance
    Table ARALEZ PHARMS Blood system drugs Business SWOT Analysis and Forecast
    Table ARALEZ PHARMS Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure ARALEZ PHARMS Blood system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure ARALEZ PHARMS Blood system drugs Sales Market Share (%) in Global (2012-2017)
    Figure ARALEZ PHARMS Blood system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure ARALEZ PHARMS Blood system drugs Revenue Market Share (%) in Global (2012-2017)
    Table ASTRAZENECA PHARMS Company Details and Competitors
    Table ASTRAZENECA PHARMS Key Blood system drugs Models and Performance
    Table ASTRAZENECA PHARMS Blood system drugs Business SWOT Analysis and Forecast
    Table ASTRAZENECA PHARMS Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure ASTRAZENECA PHARMS Blood system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure ASTRAZENECA PHARMS Blood system drugs Sales Market Share (%) in Global (2012-2017)
    Figure ASTRAZENECA PHARMS Blood system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure ASTRAZENECA PHARMS Blood system drugs Revenue Market Share (%) in Global (2012-2017)
    Table AVEDRO INC Company Details and Competitors
    Table AVEDRO INC Key Blood system drugs Models and Performance
    Table AVEDRO INC Blood system drugs Business SWOT Analysis and Forecast
    Table AVEDRO INC Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure AVEDRO INC Blood system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure AVEDRO INC Blood system drugs Sales Market Share (%) in Global (2012-2017)
    Figure AVEDRO INC Blood system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure AVEDRO INC Blood system drugs Revenue Market Share (%) in Global (2012-2017)
    Table BARR Company Details and Competitors
    Table BARR Key Blood system drugs Models and Performance
    Table BARR Blood system drugs Business SWOT Analysis and Forecast
    Table BARR Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure BARR Blood system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure BARR Blood system drugs Sales Market Share (%) in Global (2012-2017)
    Figure BARR Blood system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure BARR Blood system drugs Revenue Market Share (%) in Global (2012-2017)
    Table BAXTER HLTHCARE Company Details and Competitors
    Table BAXTER HLTHCARE Key Blood system drugs Models and Performance
    Table BAXTER HLTHCARE Blood system drugs Business SWOT Analysis and Forecast
    Table BAXTER HLTHCARE Blood system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure BAXTER HLTHCARE Blood system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure BAXTER HLTHCARE Blood system drugs Sales Market Share (%) in Global (2012-2017)
    Figure BAXTER HLTHCARE Blood system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure BAXTER HLTHCARE Blood system drugs Revenue Market Share (%) in Global (2012-2017)
    Table BIOKEY Company Details and Competitors
    Table BRECKENRIDGE PHARM Company Details and Competitors
    Table BRISTOL MYERS SQUIBB Company Details and Competitors
    Table CHIESI USA INC Company Details and Competitors
    Table CLOVER PHARMS Company Details and Competitors
    Table EMCURE PHARMS LTD Company Details and Competitors
    Table FERRING PHARMS INC Company Details and Competitors
    Table FRESENIUS KABI USA Company Details and Competitors
    Table GENENTECH Company Details and Competitors
    Table GLAND PHARMA LTD Company Details and Competitors
    Table GLENMARK PHARMS LTD Company Details and Competitors
    Table HERITAGE PHARMA Company Details and Competitors
    Table HOSPIRA Company Details and Competitors
    Table INVAGEN PHARMS Company Details and Competitors
    Table IPCA LABS LTD Company Details and Competitors
    Table LUITPOLD Company Details and Competitors
    Table MEDICURE Company Details and Competitors
    Table MYLAN Company Details and Competitors
    Table NEW RIVER Company Details and Competitors
    Table PFIZER Company Details and Competitors
    Table Global Blood system drugs Sales () by Appliance (2012-2017)
    Figure Global Blood system drugs Sales Market Share by Appliance (2012-2017)
    Figure Global Blood system drugs Sales Market Share by Appliance in 2016
    Figure Global department of hematology Blood system drugs Sales () and Growth Rate (2012-2017)
    Figure Global Internal Medicine Blood system drugs Sales () and Growth Rate (2012-2017)
    Figure Global department of surgery Blood system drugs Sales () and Growth Rate (2012-2017)
    Figure Global Pharmacy Blood system drugs Sales () and Growth Rate (2012-2017)
    Figure Global Hospital Blood system drugs Sales () and Growth Rate (2012-2017)
    Figure Global Blood system drugs Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure Global Blood system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Blood system drugs Price () Trend Forecast (2017-2022)
    Table Global Blood system drugs Sales () Forecast by Regions (2017-2022)
    Table Global Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Blood system drugs Sales Volume Share Forecast by Regions in 2022
    Table Global Blood system drugs Sales () Forecast by Application (2017-2022)
    Figure Global Blood system drugs Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Blood system drugs Sales Volume Market Share Forecast by Application in 2022
    Table Global Blood system drugs Sales () Forecast by Antianemic Agents (2017-2022)
    Figure Global Blood system drugs Sales () Forecast by Antianemic Agents (2017-2022)
    Figure Global Blood system drugs Sales Volume Market Share Forecast by Antianemic Agents in 2022
    Table Global Blood system drugs Sales () Forecast by Antiplatelet drug (2017-2022)
    Figure Global Blood system drugs Sales () Forecast by Antiplatelet drug (2017-2022)
    Figure Global Blood system drugs Sales Volume Market Share Forecast by Antiplatelet drug in 2022
    Table Global Blood system drugs Sales () Forecast by Coagulant Drugs (2017-2022)
    Figure Global Blood system drugs Sales () Forecast by Coagulant Drugs (2017-2022)
    Figure Global Blood system drugs Sales Volume Market Share Forecast by Coagulant Drugs in 2022
    Table Global Blood system drugs Sales () Forecast by Anticoagulant and thrombolytic (2017-2022)
    Figure Global Blood system drugs Sales () Forecast by Anticoagulant and thrombolytic (2017-2022)
    Figure Global Blood system drugs Sales Volume Market Share Forecast by Anticoagulant and thrombolytic in 2022
    Table Global Blood system drugs Sales () Forecast by blood volume expander (2017-2022)
    Figure Global Blood system drugs Sales () Forecast by blood volume expander (2017-2022)
    Figure Global Blood system drugs Sales Volume Market Share Forecast by blood volume expander in 2022